Literature DB >> 17052315

Risk factors and independent predictors of survival in patients with pulmonary epithelioid haemangioendothelioma. Review of the literature and a case report.

Randa M S Amin1, Kenzo Hiroshima, Takeshi Kokubo, Masafumi Nishikawa, Makoto Narita, Motoo Kuroki, Yukio Nakatani.   

Abstract

Pulmonary epithelioid haemangioendothelioma (PEH) is a rare pulmonary neoplasm. A patient with PEH with lymph node and pleural metastases that were discovered incidentally is described. An abnormal left upper lobe shadow was noticed on CXR in a 70-year-old woman during an assessment for the sudden onset of nausea and vomiting. Transbronchial lung biopsy did not provide a diagnosis. Lobectomy and lymph node resection were performed. The histological diagnosis of PEH was confirmed immunohistochemically by positive reactions to factor VIII-related antigen and CD34. Data on 93 patients with PEH including the present case report were analysed by Cox regression analysis using forward stepwise method to identify the risk factors, and the independent predictors of survival in patients with PEH. It revealed that male, symptomatic patients, presence of cough, haemoptysis, chest pain, multiple unilateral nodules, pleural effusion, metastases to more than one site and lymph node metastases were all significant risk factors for PEH (P<0.05). Symptomatic patients and presence of pleural effusion were the independent predictors of survival in patients with PEH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052315     DOI: 10.1111/j.1440-1843.2006.00923.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  31 in total

1.  Cardiac tamponade caused by epithelioid haemangioendothelioma.

Authors:  Tzu-Tao Chen; Chuan-Tsai Lai; Chien-Liang Wu; Tao-Yeuan Wang; Bing-Fu Shih; Chung-Lieh Hung; Li-Kuo Kuo; Yu-Ling Weng; Shih-Yi Lee
Journal:  BMJ Case Rep       Date:  2009-03-20

2.  The computed tomographic findings of pulmonary epithelioid hemangioendothelioma.

Authors:  Kefu Liu; Ping Xie; Weijun Peng; Zhengrong Zhou
Journal:  Radiol Med       Date:  2014-04-09       Impact factor: 3.469

Review 3.  Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ-CAMTA1 Fusion Driven Sarcoma.

Authors:  Caleb N Seavey; Ajaybabu V Pobbati; Brian P Rubin
Journal:  Cancers (Basel)       Date:  2022-06-16       Impact factor: 6.575

Review 4.  Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment.

Authors:  Ari Rosenberg; Mark Agulnik
Journal:  Curr Treat Options Oncol       Date:  2018-03-15

5.  Multiple organ metastases of Pulmonary Epithelioid Haemangioendothelioma and a review of the literature.

Authors:  Bo Ye; Wang Li; Xiang-Yang Liu; Ke-Ling Sun; Long-Hai Yang; Ke Ma; Shou-Hua Zhao; You-Sheng Mao
Journal:  Med Oncol       Date:  2009-03-11       Impact factor: 3.064

6.  Epithelioid hemangioendothelioma: evaluation by 18F-FDG PET/CT.

Authors:  Livia Maria Frota Lima; Annie T Packard; Stephen M Broski
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-04-15

Review 7.  Pulmonary epithelioid hemangioendothelioma: report of three cases.

Authors:  Torsten Schattenberg; Richard Kam; Michael Klopp; Esther Herpel; Philipp Albert Schnabel; Gunhild Mechtersheimer; Hendrik Dienemann; Joachim Pfannschmidt
Journal:  Surg Today       Date:  2008-08-28       Impact factor: 2.549

8.  Primary Pulmonary Epithelioid Hemangioendothelioma: A Rare Cause of PET-Negative Pulmonary Nodules.

Authors:  Riccardo Cazzuffi; Nunzio Calia; Franco Ravenna; Claudio Pasquini; Sara Saturni; Giorgio Narciso Cavallesco; Francesco Quarantotto; Rosa Rinaldi; Annaluisa Cogo; Gaetano Caramori; Alberto Papi
Journal:  Case Rep Med       Date:  2011-08-22

9.  Four-year natural clinical course of pulmonary epithelioid hemangioendothelioma without therapy.

Authors:  Akira Haro; Genkichi Saitoh; Sadafumi Tamiya; Akira Nagashima
Journal:  Thorac Cancer       Date:  2015-07-02       Impact factor: 3.500

10.  Treatment of pulmonary epithelioid hemangioendothelioma with combination chemotherapy: Report of three cases and review of the literature.

Authors:  Bo Ye; Wang Li; Jian Feng; Jian-Xin Shi; Yong Chen; Bao-Hui Han
Journal:  Oncol Lett       Date:  2013-02-28       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.